Explore more publications!

France Daily Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on France Daily Times.

Press releases published on January 12, 2026

Stanley Slaczka is announcing the release of his book, ‘The Structure of Perseverance!’
Stand Up for Science Receives 2025 Prix de l’Union Rationaliste
SubLeadIt Launches to Automate Reddit Replies, DMs, and Lead Generation
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 décembre 2025
Technip Energies announces dates for full-year 2025 results and 2026 quarterly results
Technip Energies annonce les dates de publication des résultats annuels 2025 et des résultats trimestriels pour l’année 2026
LECTRA: Half-year statement on the liquidity contract  Second half of 2025
 Oncovita announces a strategic partnership with Infinitusbio.AI to explore the design and optimize the development of new therapeutic candidates from its Measovir® platform.
EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance
The Bonduelle Group reaches a major milestone with B Corp certification for all its activities worldwide
Sodexo again recognized with CDP “A” rating for climate action – reinforcing its sustainability leadership within the industry
Sodexo une nouvelle fois reconnu par CDP avec la note « A » pour son action climatique - renforçant son leadership sectoriel en matière de durabilité
VALLOUREC REMPORTE UN IMPORTANT CONTRAT AVEC SHELL AU BRÉSIL
Viridien : Full-year 2025 financial update
VALLOUREC WINS A SIGNIFICANT CONTRACT WITH SHELL IN BRAZIL
Communiqué de presse : Teizeild de Sanofi approuvé dans l'UE pour les patients atteints de diabète de type 1 de stade 2
Press Release: Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions